A company still losing money with growing sales.
Facts from SEC filings, not a recommendation.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: share count not growing. A checklist is a starting point for research, not a verdict.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions cut 65.3% from their holdings. 79 bought, 30 sold.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Jean-pierre EnguentVice President, R&DSS | Sell | 35K | $2.46 | $86K | 0 | Oct 6Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
35,000 shares at $2.46 · $86K
24,810 shares
17,487 shares
8,268 shares
15,000 shares at $2.40 · $36K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page